Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

NCT00030862 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: cisplatin
DRUG: irinotecan hydrochloride

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]